Product NDC: | 61715-016 |
Proprietary Name: | Loratadine and Pseudoephedrine |
Non Proprietary Name: | Loratadine and Pseudoephedrine |
Active Ingredient(s): | 10; 240 mg/1; mg/1 & nbsp; Loratadine and Pseudoephedrine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61715-016 |
Labeler Name: | Kinray |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | ANDA076557 |
Marketing Category: | ANDA |
Start Marketing Date: | 20041117 |
Package NDC: | 61715-016-15 |
Package Description: | 15 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (61715-016-15) |
NDC Code | 61715-016-15 |
Proprietary Name | Loratadine and Pseudoephedrine |
Package Description | 15 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (61715-016-15) |
Product NDC | 61715-016 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Loratadine and Pseudoephedrine |
Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20041117 |
Marketing Category Name | ANDA |
Labeler Name | Kinray |
Substance Name | LORATADINE; PSEUDOEPHEDRINE SULFATE |
Strength Number | 10; 240 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |